Molecular formula: | C33H35FN2O6 |
Average mass: | 574.649 |
Monoisotopic mass: | 574.247915 |
ChemSpider ID: | 7983984 |
2 of 2 defined stereocentres
(3R,5R)-7-(2-(4-fluorophenyl)-4-((2-hydroxyphenyl)carbamoyl)-5-isopropyl-3-phenyl-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid
(3R,5R)-7-{2-(4-Fluorophenyl)-4-[(2-hydroxyphenyl)carbamoyl]-5-isopropyl-3-phenyl-1H-pyrrol-1-yl}-3,5-dihydroxyheptanoic acid
[ACD/IUPAC Name](3R,5R)-7-{2-(4-Fluorphenyl)-4-[(2-hydroxyphenyl)carbamoyl]-5-isopropyl-3-phenyl-1H-pyrrol-1-yl}-3,5-dihydroxyheptansäure
[German]
[ACD/IUPAC Name]1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-4-[[(2-hydroxyphenyl)amino]carbonyl]-5-(1-methylethyl)-3-phenyl-, (betaR,deltaR)-
[ACD/Index Name]214217-86-4
[RN]Acide (3R,5R)-7-{2-(4-fluorophényl)-4-[(2-hydroxyphényl)carbamoyl]-5-isopropyl-3-phényl-1H-pyrrol-1-yl}-3,5-dihydroxyheptanoïque
[French]
[ACD/IUPAC Name]ORTHOHYDROXYATORVASTATIN
(3R,5R)-7-(2-(4-fluorophenyl)-4-(2-hydroxyphenylcarbamoyl)-5-isopropyl-3-phenyl-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid
(3R,5R)-7-[2-(4-fluorophenyl)-4-[(2-hydroxyphenyl)carbamoyl]-3-phenyl-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid
(3R,5R)-7-[2-(4-fluorophenyl)-4-[(2-hydroxyphenyl)carbamoyl]-3-phenyl-5-propan-2-yl-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid
(3R,5R)-7-[2-(4-fluorophenyl)-4-[(2-hydroxyphenyl)carbamoyl]-3-phenyl-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid
(3r,5r)-7-[2-(4-Fluorophenyl)-4-[(2-Hydroxyphenyl)carbamoyl]-5-(1-Methylethyl)-3-Phenyl-1h-Pyrrol-1-Yl]-3,5-Dihydroxyheptanoic Acid
(3R,5R)-7-[2-(4-fluorophenyl)-4-[(2-hydroxyphenyl)carbamoyl]-5-isopropyl-3-phenyl-pyrrol-1-yl]-3,5-dihydroxy-enanthic acid
(3R,5R)-7-[2-(4-fluorophenyl)-4-[(2-hydroxyphenyl)carbamoyl]-5-isopropyl-3-phenyl-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid
(3R,5R)-7-[2-(4-fluorophenyl)-4-[[(2-hydroxyphenyl)amino]-oxomethyl]-5-isopropyl-3-phenyl-1-pyrrolyl]-3,5-dihydroxyheptanoic acid
265989-46-6
[RN]3HI
400615-32-9
[RN]MFCD07357498
[MDL number]o-hydroxyatorvastatin
ortho-Hydroxy atorvastatin